Davercin, a cyclocarbonate derivative of erythromycin, is a research compound with antibacterial activity against Gram-positive and certain Gram-negative bacteria. It is utilized in microbiological and pharmacological studies, including in vitro susceptibility assays and in vivo infection model research.
